by Clinical Neuropsychologist | Thursday, August 15, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 15, 2024 Wiley: Alzheimer’s & Dementia:...
by Clinical Neuropsychologist | Wednesday, August 14, 2024 | Dementia
Dementia, Volume 23, Issue 8, Page 1292-1306, November 2024. Background and ObjectivesPublic health messaging increasingly emphasizes the importance of “lifestyle interventions” to reduce dementia risk. Our study aimed to understand how people interpret and respond to...
by Clinical Neuropsychologist | Wednesday, August 14, 2024 | Dementia
Abstract The goal of the Biostatistics Core of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) has been to ensure that sound study designs and statistical methods are used to meet the overall goals of ADNI. We have supported the creation of a...
by Clinical Neuropsychologist | Wednesday, August 14, 2024 | Dementia
Abstract The Alzheimer’s Disease Neuroimaging Initiative (ADNI) has revolutionized the landscape of Alzheimer’s research through its Informatics Core, which has facilitated unprecedented data standardization and sharing. Over 20 years, ADNI established a...
by Clinical Neuropsychologist | Wednesday, August 14, 2024 | Dementia
Abstract Black women are sorely underrepresented in studies of Alzheimer’s disease and related dementias (ADRD) despite higher rates of ADRD diagnoses than in non-Hispanic White women. There are many reasons for underrepresentation, including medical mistrust,...
by Clinical Neuropsychologist | Wednesday, August 14, 2024 | Dementia
Abstract INTRODUCTION Brain glucose hypometabolism, indexed by the fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) imaging, is a metabolic signature of Alzheimer’s disease (AD). However, the underlying biological pathways involved in these...
